These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29199890)

  • 1. Application of magnetic resonance spectroscopy in geriatric mood disorders.
    Mathias LK; Monette PJ; Harper DG; Forester BP
    Int Rev Psychiatry; 2017 Dec; 29(6):597-617. PubMed ID: 29199890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.
    Cecil KM; DelBello MP; Sellars MC; Strakowski SM
    J Child Adolesc Psychopharmacol; 2003; 13(4):545-55. PubMed ID: 14977467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cluster analysis reveals abnormal hippocampal neurometabolic profiles in young people with mood disorders.
    Hermens DF; Naismith SL; Chitty KM; Lee RS; Tickell A; Duffy SL; Paquola C; White D; Hickie IB; Lagopoulos J
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):836-45. PubMed ID: 25795519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of affected and unaffected relatives of patients with bipolar disorder using proton magnetic resonance spectroscopy.
    Hajek T; Bernier D; Slaney C; Propper L; Schmidt M; Carrey N; MacQueen G; Duffy A; Alda M
    J Psychiatry Neurosci; 2008 Nov; 33(6):531-40. PubMed ID: 18982176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances and Barriers for Clinical Neuroimaging in Late-Life Mood and Anxiety Disorders.
    Ly M; Andreescu C
    Curr Psychiatry Rep; 2018 Mar; 20(1):7. PubMed ID: 29492705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological changes of the brain in mood disorders.
    Wilczyńska K; Simonienko K; Konarzewska B; Szajda SD; Waszkiewicz N
    Psychiatr Pol; 2018 Oct; 52(5):797-805. PubMed ID: 30584814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood disorders: treatment-induced changes in brain neurochemistry and structure.
    Glitz DA; Manji HK; Moore GJ
    Semin Clin Neuropsychiatry; 2002 Oct; 7(4):269-80. PubMed ID: 12382209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders.
    Moore GJ; Galloway MP
    Psychopharmacol Bull; 2002; 36(2):5-23. PubMed ID: 12397837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopy: current and future applications in psychiatric research.
    Lyoo IK; Renshaw PF
    Biol Psychiatry; 2002 Feb; 51(3):195-207. PubMed ID: 11839362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Spectroscopy for Psychiatry: Progress in the Last Decade.
    Port JD
    Neuroimaging Clin N Am; 2020 Feb; 30(1):25-33. PubMed ID: 31759569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.
    Forester BP; Finn CT; Berlow YA; Wardrop M; Renshaw PF; Moore CM
    Bipolar Disord; 2008 Sep; 10(6):691-700. PubMed ID: 18837863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders.
    Soares JC; Krishnan KR; Keshavan MS
    Depression; 1996; 4(1):14-30. PubMed ID: 9160650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Magnetic Resonance Spectroscopy Study of Lovastatin for Treating Bipolar Mood Disorder: A 4-Week Randomized Double-Blind, Placebo- Controlled Clinical Trial.
    Lotfi M; Shafiee S; Ghanizadeh A; Sigaroudi MO; Razeghian L
    Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):133-141. PubMed ID: 27804862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain GABA levels in patients with bipolar disorder.
    Kaufman RE; Ostacher MJ; Marks EH; Simon NM; Sachs GS; Jensen JE; Renshaw PF; Pollack MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):427-34. PubMed ID: 19171176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of machine learning classification for structural brain MRI in mood disorders: Critical review from a clinical perspective.
    Kim YK; Na KS
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt B):71-80. PubMed ID: 28648568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectroscopic correlates of antidepressant response to sleep deprivation and light therapy: a 3.0 Tesla study of bipolar depression.
    Benedetti F; Calabrese G; Bernasconi A; Cadioli M; Colombo C; Dallaspezia S; Falini A; Radaelli D; Scotti G; Smeraldi E
    Psychiatry Res; 2009 Sep; 173(3):238-42. PubMed ID: 19682864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging studies of mood disorder effects on the brain.
    Sheline YI
    Biol Psychiatry; 2003 Aug; 54(3):338-52. PubMed ID: 12893109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders.
    Stanley JA
    Can J Psychiatry; 2002 May; 47(4):315-26. PubMed ID: 12025430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging studies in early-onset bipolar disorder: a critical review.
    Frazier JA; Ahn MS; DeJong S; Bent EK; Breeze JL; Giuliano AJ
    Harv Rev Psychiatry; 2005; 13(3):125-40. PubMed ID: 16020026
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.